Search
How protective is the whooping cough vaccine? Vaccination and allergy Even though Australia has high vaccination rates against whooping cough, we
Help us discover a way to expand protection for the next generation.
The Healthy Skin team, in collaboration with Elder Researchers and Aboriginal Community Members, is working to strengthen sun safety knowledge, practices, and skin cancer risk awareness among Aboriginal children and young people in Western Australia.
ATOMIC Ears Study The ATOMIC Ears Study aims to evaluate a new treatment designed to prevent ongoing ear infections in kids having grommet surgery.
News & Events
STEM festival is coming to Kalgoorlie this AugustFree Family-Friendly Science Fun During National Science Week 2025. Get ready for an awesome adventure into the world of Science, Technology, Engineering and Mathematics!
Research
MeaslesMeasles is a highly contagious infectious disease that can cause severe, long-term complications in children.
Research
Understanding motivation and experience in participating in a paediatric SARS-CoV-2 serosurvey, in AustraliaSerosurveys are considered as a valuable tool in estimating population immunity and infection rates but recruitment of children to provide paediatric estimates can be challenging. A novel approach of sampling children undergoing anaesthesia was utilised for a SARS-CoV-2 serosurvey in Australian children and we explore the reasons for participation, feedback on the approach and importance of research into Coronavirus Diseases 2019 (COVID-19).
Research
Convalescent plasma in hospitalised patients with COVID-19Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.
Research
Ontogeny of plasma cytokine and chemokine concentrations across the first four months of human life in a Papua new Guinean cohortDynamic molecular changes in early life follow a robust ontogeny as the infant immune system adapts to the demands of its new environment. Studies of plasma immunomodulatory cytokines and chemokines have previously demonstrated ontogenetic patterns of immune development across the first week of life. However, how plasma cytokine and chemokines concentrations evolve over the first 4 months of life remains unknown.
Research
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and designBringing optimised coronavirus disease 2019 (COVID-19) vaccine schedules to immunocompromised populations (BOOST-IC) is a multi-site, adaptive platform trial designed to assess the effect of different booster vaccination schedules in the Australian immunocompromised population on the immunogenicity, safety and cross-protection against COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants.